1-155610565-G-C
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 1P and 0B. PP3
The NM_018116.4(MSTO1):c.220+5G>C variant causes a splice donor 5th base, intron change. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000063 ( 0 hom., cov: 19)
Exomes 𝑓: 0.000076 ( 0 hom. )
Failed GnomAD Quality Control
Consequence
MSTO1
NM_018116.4 splice_donor_5th_base, intron
NM_018116.4 splice_donor_5th_base, intron
Scores
2
Splicing: ADA: 0.9992
2
Clinical Significance
Conservation
PhyloP100: 3.75
Genes affected
MSTO1 (HGNC:29678): (misato mitochondrial distribution and morphology regulator 1) Involved in mitochondrion distribution. Located in cytosol and mitochondrial outer membrane. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 1 ACMG points.
PP3
?
Splicing scoreres supports a deletorius effect: Scorers claiming Pathogenic: dbscSNV1_ADA, dbscSNV1_RF, max_spliceai. No scorers claiming Uncertain. No scorers claiming Benign.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
MSTO1 | NM_018116.4 | c.220+5G>C | splice_donor_5th_base_variant, intron_variant | ENST00000245564.8 | |||
LOC105371452 | XR_922171.2 | n.77-673C>G | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
MSTO1 | ENST00000245564.8 | c.220+5G>C | splice_donor_5th_base_variant, intron_variant | 1 | NM_018116.4 | P1 |
Frequencies
GnomAD3 genomes ? AF: 0.00 AC: 9AN: 143732Hom.: 0 Cov.: 19 FAILED QC
GnomAD3 genomes
?
AF:
AC:
9
AN:
143732
Hom.:
Cov.:
19
FAILED QC
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000325 AC: 2AN: 61574Hom.: 0 AF XY: 0.0000323 AC XY: 1AN XY: 30986
GnomAD3 exomes
AF:
AC:
2
AN:
61574
Hom.:
AF XY:
AC XY:
1
AN XY:
30986
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.0000761 AC: 57AN: 749220Hom.: 0 Cov.: 10 AF XY: 0.0000680 AC XY: 26AN XY: 382472
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
57
AN:
749220
Hom.:
Cov.:
10
AF XY:
AC XY:
26
AN XY:
382472
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome ? Data not reliable, filtered out with message: AS_VQSR AF: 0.0000626 AC: 9AN: 143732Hom.: 0 Cov.: 19 AF XY: 0.0000720 AC XY: 5AN XY: 69484
GnomAD4 genome
?
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
9
AN:
143732
Hom.:
Cov.:
19
AF XY:
AC XY:
5
AN XY:
69484
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Pathogenic:1Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
See cases Pathogenic:1
Pathogenic, no assertion criteria provided | research | Laboratory of Genetics in Ophthalmology, Institut Imagine | Jun 17, 2022 | The c.220+5 variant in MSTO1 has been identified in compound heterozygosity with a likely pathogenic missense change (c.65A>G, p.Ala22Glu) in three siblings affected with typical MSTO1-assciated myoptahy, cerbellar atrophy and corticospinal track involvement and previously unreported bilateral optic neuropathy responsible for profound central visual loss. Biallelism has been demonstrated experimentaly. The change is known as rs1187504822 and is extremely rare with a minor allele frequency of 0.003%. The variant is predicted to abolish the donor splice-site of intron 2, induce exon skipping and introduce a premature termination codon in the mRNA. The mRNA encoded by the allele carrying the c.200+5G>C variant is undetectable in cells from affected individuals, suggesting nonsense-mediated mRNA decay. In summary, the c.220+5G>C variant meets our criteria to be classified as pathogenic based upon phenotype, family history, segregation studies, rarity in large population studies, computational evidence supporting deleterious effect and mRNA analysis. - |
Mitochondrial myopathy-cerebellar ataxia-pigmentary retinopathy syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | May 31, 2023 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
Cadd
Benign
Dann
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Pathogenic
dbscSNV1_RF
Pathogenic
SpliceAI score (max)
Details are displayed if max score is > 0.2
DS_DL_spliceai
Position offset: -5
Find out detailed SpliceAI scores and Pangolin per-transcript scores at